Please enable Javascript
Yohann Loriot, MD, PhD
Yohann Loriot, MD, PhD, Institute Gustave Roussy
Articles by Yohann Loriot, MD, PhD
Drs. Loriot, Koshkin on Results From Cohort 1 of the THOR Study
Yohann Loriot, MD, PhD
ASCO 2023
|
August 1, 2023
Drs. Loriot, Koshkin summarize erdafitinib versus chemotherapy in patients with advanced UC with select FGFR alterations.
View More